Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition
Fateen Ata, Hiba Magboul, Haneen Toba, Hadeel Alfar, Adel Al Bozom, Khaled Murshed, Muhammad Zahid
Clinical Case Reports · 2022-12
Abstract
Rifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin-induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.
MeSH terms
- Medicine
- Hemolysis
- Rifampicin
- Nephrotoxicity
- Acute kidney injury
- Tuberculosis
- Acute tubular necrosis
- Drug
- Intensive care medicine
- Kidney
- Pharmacology